Owlstone Medical has developed a breathalyzer for disease. Our vision is to change the way we currently diagnose and monitor serious disease; we aim to be become the global leader in the non-invasive detection of cancer, infectious disease and inflammatory disease. Through early detection we have set ourselves a goal to save 100,000 lives and $1.5B in health care costs.

My main task, as part of the Clinical Science team, is to design, review and follow-up on the biomedical-translational phase of our studies. Our mission is to translate the R&D developments into operational, clinically-oriented systems and to put them to the test, under real-world conditions via multi-centered clinical trials.